Fig. 1
From: Predictive value of RAD51 on the survival and drug responsiveness of ovarian cancer
Expression profile of RAD51 in ovarian cancer. a Clinicopathological characteristics of TCGA ovarian cancer patients and genetic signatures of RAD51 were studied in detail and depicted as oncoprints using cBioPortal. b Comparison of RAD51 expression between TCGA ovarian cancer tissues and matched GTEx normal tissues in GEPIA (one-way ANOVA). c Proportion of patients who developed new neoplasm events post initial therapy was analyzed in cBioPortal. d The effect of RAD51 expression on disease-free months of ovarian cancer patients was evaluated and survival analysis was performed (log-rank test). P value was denoted as *P < 0.05